Insitro picks up $400M for drug development
March 16, 2021- Share:
Insitro has raised a $400 million Series C led by Canada Pension Plan Investment Board, with participation from investors including Andreessen Horowitz, Casdin Capital, HOF Capital, Two Sigma Ventures, Temasek and Arch Venture Partners. The South San Francisco-based company uses machine learning to create predictive disease models for drug development and delivery. Insitro raised a $143 million Series B in May.
Additional Investors
- Share:
-
-
-
-